Vanguard Group’s EndoChoice Holdings, Inc. GI Stock Holding History

Vanguard Group’s Portfolio GI Stock Details GI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-370,317	Closed	-$2.96M	–	4115
2016 Q3	$2.96M	Buy	370,317 +95,350	+35%	+$447K	﹤0.01%	3235
2016 Q2	$1.35M	Buy	274,967 +33,427	+14%	+$159K	﹤0.01%	3519
2016 Q1	$1.26M	Buy	241,540 +65,372	+37%	+$359K	﹤0.01%	3534
2015 Q4	$1.47M	Buy	176,168 +39,538	+29%	+$380K	﹤0.01%	3508
2015 Q3	$1.55M	Buy	136,630 +111,655	+447%	+$1.75M	﹤0.01%	3483
2015 Q2	$408K	Buy	+24,975	New	+$415K	﹤0.01%	3916

Vanguard Group's GI Position: Q4 2016 in Review

Vanguard Group sold out of EndoChoice Holdings, Inc. (GI) in Q4 2016, closing a stake of 370,317 shares — an estimated $2.96M sold.

Vanguard Group first reported a position in GI in Q2 2015 and held it in 6 quarters. The position peaked at $2.96M in Q3 2016. 0 funds tracked by Wall St. Rank hold GI as of Q4 2016.

Vanguard Group reported no remaining EndoChoice Holdings, Inc. position as of Q4 2016 after selling out during the quarter.
Vanguard Group sold 370,317 EndoChoice Holdings, Inc. shares in Q4 2016, an estimated $2.96M.
Vanguard Group first reported a position in EndoChoice Holdings, Inc. in Q2 2015 and held it in 6 quarters.
Vanguard Group's EndoChoice Holdings, Inc. position peaked at $2.96M in Q3 2016.
0 funds tracked by Wall St. Rank held EndoChoice Holdings, Inc. as of Q4 2016.

Based on Vanguard Group's 13F filing for Q4 2016, filed 14 Feb 2017.